{"transactions":[{"id":1557774,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":92545,"kind":"person","name":"Barrage Khalil","position":1,"cik":"0001666011","reported_name":"Barrage Khalil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"PTIX Common stock Options","published_at":"2024-03-30T01:29:19.000Z","date":"2024-03-25","kind":"grant","planned":false,"acquired":true,"shares":22500,"price":1.74,"value":39150.0,"ownership":{"direct":true},"balance_after":22500,"derivative":{"exercise_price":1.74,"exercise_date":"2026-03-25","expiration_date":"2034-03-25","underlying":"PTIX common stock, Par Value $0.0001","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001493152-24-012070","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000149315224012070/ownership.xml","form_type":"4"}},{"id":2689658,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":92545,"kind":"person","name":"Barrage Khalil","position":1,"cik":"0001666011","reported_name":"Barrage Khalil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"PTIX Common stock NSO Options","published_at":"2021-06-01T22:54:37.000Z","date":"2021-05-26","kind":"grant","acquired":true,"shares":180000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This exercise price was determined by the Board of Directors at a Board Meeting held May 26, 2021."},{"field":"shares","element":"transactionShares","label":"F2","text":"This number of options was determined by the Board of Directors at a Board Meeting held May 26, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options are fully vested."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"This number of options was determined by the Board of Directors at a Board Meeting held May 26, 2021."}],"balance_after":180000,"derivative":{"exercise_price":3.65,"expiration_date":"2031-05-26","underlying":"PTIX common stock, Par Value $0.000001","underlying_shares":180000},"source":{"system":"sec-edgar","filing":"0001493152-21-013384","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000149315221013384/ownership.xml","form_type":"4"}},{"id":2727987,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":92545,"kind":"person","name":"Barrage Khalil","position":1,"cik":"0001666011","reported_name":"Barrage Khalil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"PTIX Common stock Options","published_at":"2021-05-05T10:10:19.000Z","date":"2021-05-03","kind":"exercise","acquired":false,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents a cash exercise of stock options in which the reporting person paid the exercise price of such options in cash. No shares were sold by the reporting person in connection with this transaction."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options are fully vested."}],"balance_after":0,"derivative":{"exercise_price":1.75,"expiration_date":"2030-02-13","underlying":"PTIX common stock, Par Value $0.000001","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001493152-21-010465","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000149315221010465/ownership.xml","form_type":"4"}},{"id":2727986,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":92545,"kind":"person","name":"Barrage Khalil","position":1,"cik":"0001666011","reported_name":"Barrage Khalil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"PTIX Common stock Options","published_at":"2021-05-05T10:10:19.000Z","date":"2021-05-03","kind":"exercise","acquired":false,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents a cash exercise of stock options in which the reporting person paid the exercise price of such options in cash. No shares were sold by the reporting person in connection with this transaction."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options are fully vested."}],"balance_after":120000,"derivative":{"exercise_price":1.75,"expiration_date":"2027-10-16","underlying":"PTIX common stock, Par Value $0.000001","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001493152-21-010465","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000149315221010465/ownership.xml","form_type":"4"}},{"id":2727985,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":92545,"kind":"person","name":"Barrage Khalil","position":1,"cik":"0001666011","reported_name":"Barrage Khalil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"PTIX Common stock Options","published_at":"2021-05-05T10:10:19.000Z","date":"2021-05-03","kind":"exercise","acquired":false,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents a cash exercise of stock options in which the reporting person paid the exercise price of such options in cash. No shares were sold by the reporting person in connection with this transaction."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options are fully vested."}],"balance_after":165000,"derivative":{"exercise_price":1.25,"expiration_date":"2027-01-01","underlying":"PTIX common stock, Par Value $0.000001","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001493152-21-010465","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000149315221010465/ownership.xml","form_type":"4"}},{"id":2727984,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":92545,"kind":"person","name":"Barrage Khalil","position":1,"cik":"0001666011","reported_name":"Barrage Khalil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"PTIX Common stock Options","published_at":"2021-05-05T10:10:19.000Z","date":"2021-05-03","kind":"exercise","acquired":false,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents a cash exercise of stock options in which the reporting person paid the exercise price of such options in cash. No shares were sold by the reporting person in connection with this transaction."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options are fully vested."}],"balance_after":315000,"derivative":{"exercise_price":1.25,"expiration_date":"2026-04-15","underlying":"PTIX common stock, Par Value $0.000001","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001493152-21-010465","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000149315221010465/ownership.xml","form_type":"4"}},{"id":2727983,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":92545,"kind":"person","name":"Barrage Khalil","position":1,"cik":"0001666011","reported_name":"Barrage Khalil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Protagenic Therapeutics, Inc. Common Stock","published_at":"2021-05-05T10:10:19.000Z","date":"2021-05-03","kind":"exercise","acquired":true,"shares":120000,"price":1.75,"value":210000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"$532,500.00 was paid in cash by the reporting person as consideration for the aggregate option exercise."}],"balance_after":410000,"source":{"system":"sec-edgar","filing":"0001493152-21-010465","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000149315221010465/ownership.xml","form_type":"4"}},{"id":2727982,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":92545,"kind":"person","name":"Barrage Khalil","position":1,"cik":"0001666011","reported_name":"Barrage Khalil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Protagenic Therapeutics, Inc. Common Stock","published_at":"2021-05-05T10:10:19.000Z","date":"2021-05-03","kind":"exercise","acquired":true,"shares":45000,"price":1.75,"value":78750.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"$532,500.00 was paid in cash by the reporting person as consideration for the aggregate option exercise."}],"balance_after":290000,"source":{"system":"sec-edgar","filing":"0001493152-21-010465","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000149315221010465/ownership.xml","form_type":"4"}},{"id":2727981,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":92545,"kind":"person","name":"Barrage Khalil","position":1,"cik":"0001666011","reported_name":"Barrage Khalil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Protagenic Therapeutics, Inc. Common Stock","published_at":"2021-05-05T10:10:19.000Z","date":"2021-05-03","kind":"exercise","acquired":true,"shares":150000,"price":1.25,"value":187500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"$532,500.00 was paid in cash by the reporting person as consideration for the aggregate option exercise."}],"balance_after":245000,"source":{"system":"sec-edgar","filing":"0001493152-21-010465","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000149315221010465/ownership.xml","form_type":"4"}},{"id":2727980,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":92545,"kind":"person","name":"Barrage Khalil","position":1,"cik":"0001666011","reported_name":"Barrage Khalil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Protagenic Therapeutics, Inc. Common Stock","published_at":"2021-05-05T10:10:19.000Z","date":"2021-05-03","kind":"exercise","acquired":true,"shares":45000,"price":1.25,"value":56250.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"$532,500.00 was paid in cash by the reporting person as consideration for the aggregate option exercise."}],"balance_after":95000,"source":{"system":"sec-edgar","filing":"0001493152-21-010465","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000149315221010465/ownership.xml","form_type":"4"}},{"id":3246916,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":92545,"kind":"person","name":"Barrage Khalil","position":1,"cik":"0001666011","reported_name":"Barrage Khalil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"PTIX Common stock Options","published_at":"2020-02-27T01:29:04.000Z","date":"2020-02-21","kind":"grant","acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":120000,"derivative":{"exercise_price":1.75,"exercise_date":"2021-02-21","expiration_date":"2030-02-21","underlying":"PTIX common stock, Par Value $0.0001","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001493152-20-003041","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000149315220003041/ownership.xml","form_type":"4"}},{"id":3253892,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":92545,"kind":"person","name":"Barrage Khalil","position":1,"cik":"0001666011","reported_name":"Barrage Khalil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Convertible Note","published_at":"2020-02-24T19:16:10.000Z","date":"2019-11-05","kind":"purchase","acquired":true,"price":50000,"reported_value":50000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reported transaction is the purchase of a convertible note, convertible at the holder's discretion at any time into common stock at the rate of $1.25 per share."}],"derivative":{"exercise_price":1.25,"exercise_date":"2019-11-05","expiration_date":"2023-11-06","underlying":"Common stock, par value $0.0001 per share","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001493152-20-002881","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000149315220002881/ownership.xml","form_type":"5"}},{"id":4184191,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":92545,"kind":"person","name":"Barrage Khalil","position":1,"cik":"0001666011","reported_name":"Barrage Khalil","relationship":{"director":true}}],"security":"Non-Qualified Stock Options (Right to Buy)","published_at":"2017-10-18T18:13:26.000Z","date":"2017-10-16","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting in equal installments over 18 months"}],"balance_after":45000,"derivative":{"exercise_price":1.75,"expiration_date":"2027-10-16","underlying":"Protagenic Therapeutics, Inc. Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001437749-17-017233","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000143774917017233/rdgdoc.xml","form_type":"4"}}]}